Indication
Squamous cell carcinoma of skin
Squamous cell carcinoma of the skin is a malignant non-melanoma cutaneous neoplasm arising from epidermal keratinocytes. Read more about Squamous cell carcinoma of skin
5 drugs 3 manufacturers
Drugs that treat it
Common Squamous cell carcinoma of skin therapies.
LIBTAYO (cemiplimab-rwlc)
KEYTRUDA POWDER (pembrolizumab)
KEYTRUDA (pembrolizumab)
KEYTRUDA QLEX (pembrolizumab-berahyaluronidase alfa-pmph)
UNLOXCYT (cosibelimab-ipdl)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonSquamous cell carcinoma of the skin is a malignant non-melanoma cutaneous neoplasm arising from epidermal keratinocytes.
It primarily affects the integumentary system, most commonly emerging in older adults, fair-skinned individuals, and immunocompromised populations on chronically sun-exposed anatomical sites such as the head, neck, and extremities.
Pathophysiologically driven by cumulative ultraviolet radiation that induces somatic mutations—notably within the *TP53* tumor suppressor gene—the malignancy is characterized by atypical keratinocyte proliferation with dermal invasion.
Clinically, it typically manifests as an indurated, hyperkeratotic papule, scaly plaque, or ulcerated nodule with potential for destructive local extension and regional lymph node metastasis.
- nih.gov
Squamous cell carcinoma of the skin is a malignant non-melanoma cutaneous neoplasm arising from epidermal keratinocytes
- mdpi.com
Squamous cell carcinoma of the skin is a malignant non-melanoma cutaneous neoplasm arising from epidermal keratinocytes
- nih.gov
It primarily affects the integumentary system, most commonly emerging in older adults, fair-skinned individuals, and immunocompromised populations on chronically sun-exposed anatomical sites such as the head, neck, and extremities Clinically, it typically manifests as an indurated, hyperkeratotic papule, scaly plaque, or ulcerated nodule with potential for destructive local extension and regional lymph node metastasis
- cancer.gov
It primarily affects the integumentary system, most commonly emerging in older adults, fair-skinned individuals, and immunocompromised populations on chronically sun-exposed anatomical sites such as the head, neck, and extremities
- merckmanuals.com
It primarily affects the integumentary system, most commonly emerging in older adults, fair-skinned individuals, and immunocompromised populations on chronically sun-exposed anatomical sites such as the head, neck, and extremities Pathophysiologically driven by cumulative ultraviolet radiation that induces somatic mutations—notably within the *TP53* tumor suppressor gene—the malignancy is characterized by atypical keratinocyte proliferation with dermal invasion Clinically, it typically manifests...
Personalize your experience
Follow Squamous cell carcinoma of skin and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.